Call Today for a FREE Consultation
Ball & Bonholtzer
Se Habla Español 626-817-6453

Breach Of Fiduciary Standard Quite High in M&A

This court ruled that the plaintiff in a breach of fiduciary duty lawsuit against a board over a merger must plead facts sufficient to show that the Board "utterly failed" to undertake any action. That's a high bar.

Delaware Court Shows Heightened Pleading Standard Necessary To Support A Claim For Breach Of Fiduciary Duty In Connection With A Merger

May 19 2014. By John Stigi and Alejandro E. Moreno via mondaq.com.

In 

Houseman v. Sagerman, C.A. No. 8898-VCG, 2014 WL 1478511 (Del. Ch. Apr. 16, 2014), the 

Delaware Court of Chancery (Glasscock, V.C.) granted, in part, a motion to dismiss filed by certain directors and the financial advisor of Universata, Inc. ("Universata" or the "Company") arising out of the Company's merger with HealthPort Technologies, LLC ("HealthPort").  The Court's analysis serves as a reminder that a stockholder plaintiff must plead an "extreme set of facts" to support a claim for breach of fiduciary duty against a corporation's directors arising out of allegations that the directors breached their duty of loyalty as a result of the process used to approve a strategic transaction.  Although the allegations suggested that Universata's board of directors (the "Board") did not conduct a "perfect" process, plaintiffs did not plead facts sufficient to show that the Board "utterly failed to undertake any action to obtain the best price for stockholders."  As a result, the Court dismissed plaintiffs' claim for breach of fiduciary duty.

Universata was a Delaware corporation focused on providing services with respect to medical records for hospitals and clinics.  In 2006, plaintiffs sold a previous business known as Med-Legal, Inc. to Universata and obtained shares in the Company and put rights to those shares whereby a director of the Company, Thomas Whittington, committed to repurchase plaintiffs' shares pursuant to the put rights.

In 2010, HealthPort approached Universata regarding a potential acquisition.  In response to HealthPort's indication of interest, the Board consulted with its legal advisors and with KeyBanc Capital Markets, Inc. ("KeyBanc"), which it hired as its financial advisor.  Due to expense, the Board limited KeyBanc's engagement to assisting in diligence and identifying additional parties with an interest in acquiring the Company.  Notably, the Board did not request that KeyBanc prepare a fairness opinion on the proposed transaction.

In May 2011, the Board approved an Agreement and Plan of Merger between Universata and HealthPort.  As a result of the merger, the stockholders of Universata would receive $1.02 per share.  In addition the stockholders of Universata would receive stock in a new corporation known as "TechCo" created to hold a patent previously held by Universata.  At the meeting approving the merger, KeyBanc advisors informally gave the opinion that the merger price was within the range of reasonableness.  Because the directors who approved the merger collectively held a majority ownership interest in the Company, the Board did not solicit a stockholder vote to approve the transaction.  Nevertheless, at the same time as the Board approved the merger, it amended a previous equity incentive plan to treat all outstanding stock options like outstanding shares upon a change in control.  In addition, the Board voted to vest all outstanding "in the money" warrants for the purchase of shares in the Company.

Plaintiffs, who were a director of the Company and his wife, approved the letter of intent with HealthPort, but did not vote or execute a consent in favor of the merger.  Two years after the merger closed, plaintiffs filed a verified complaint against certain directors of Universata and against KeyBanc asserting causes of action for (i) breach of fiduciary duty against the director defendants; (ii) an accounting against director Whittington; (iii) quasi-appraisal against Universata and the director defendants; (iv) aiding and abetting a breach of fiduciary duty against KeyBanc; and (v) for failing to obtain consideration for alleged "litigation assets."  Defendants moved to dismiss.

The Chancery Court denied defendants' motion to dismiss the accounting claim.  With respect to the other claims, the Court granted, in part, and denied, in part, defendants' motion to dismiss.

 

More ...

No Comments

Leave a comment
Comment Information
  • America's Top 100 Attorneys
  • Rated By SuperLawyers Stephen C. Ball SuperLawers.com 11 Years In A Row 2005-2006
  • American Board Of Trial Advocates
  • The National Top 100 Trial Lawyers Trial Lawyers
Email Us For A Response

Contact Us For The Help You Need

Bold labels are required.

Contact Information
disclaimer.

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.

close

Privacy Policy

BALL & BONHOLTZER TRIAL LAWYERS

Ball & Bonholtzer
300 North Lake Avenue Suite 1000
Pasadena, CA 91101

Phone: 626-817-6453
Fax: 626-793-3198
Pasadena Law Office Map